NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Neuren approaching key milestones in Q4 2019, page-21

  1. 1,293 Posts.
    lightbulb Created with Sketch. 318
    Rather than the doom merchants ball aching on here a quick email to the good Doctor will cure what ails you. Not saying you should do so every time but I have had at least a quarterly correspondence with Dr T over the past 7 years and it has only ever reinforced by confidence in both him and the company more broadly
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.